These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4565709)

  • 1. The complement sensitivity on PNH cells.
    Rosse WF
    Ser Haematol; 1972; 5(3):101-14. PubMed ID: 4565709
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The laboratory substitutes of the red cell of paroxysmal nocturnal haemoglobinuria (PNH): PNH-like red cells.
    Sirchia G; Ferrone S
    Ser Haematol; 1972; 5(3):137-75. PubMed ID: 4565711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changing complement sensitivity and PNH red cell population during the clinical course in a case of PNH with hypoplastic bone marrow].
    Shichishima T; Yoshida M; Terasawa T; Konno I; Mita M; Uchida T; Kariyone S
    Rinsho Ketsueki; 1987 Apr; 28(4):564-9. PubMed ID: 3626048
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.
    Rosse WF; Dacie JV
    J Clin Invest; 1966 May; 45(5):749-57. PubMed ID: 4956901
    [No Abstract]   [Full Text] [Related]  

  • 7. Biochemistry of PNH cells: nature of the membrane defect.
    Mengel CE; Ebbert L; Stickney D; Essig L; Brubaker L
    Ser Haematol; 1972; 5(3):88-100. PubMed ID: 4641079
    [No Abstract]   [Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria revisited.
    Schreiber AD
    N Engl J Med; 1983 Sep; 309(12):723-5. PubMed ID: 6888445
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 10. Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders.
    Risitano AM
    Immunobiology; 2012 Nov; 217(11):1080-7. PubMed ID: 22964233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
    Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
    [No Abstract]   [Full Text] [Related]  

  • 13. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells.
    Jenkins DE; Hartmann RC; Kerns AL
    J Clin Invest; 1967 May; 46(5):753-61. PubMed ID: 6025481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by acid-activated serum.
    Hänsch G; Hammer C; Jiji R; Rother U; Shin M
    Immunobiology; 1983 Mar; 164(2):118-26. PubMed ID: 6852860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new book interpretation of red blood cell heat-sensitivity in paroxysmal nocturnal haemoglobinuria (author's transl)].
    Angulo P; Fernández J; Cuesta B; Gońi M; López-Borrasca A
    Sangre (Barc); 1976; 21(4):773-81. PubMed ID: 1006495
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxysmal nocturnal hemoglobinuria, a clue disease.
    Hinz CF
    N Engl J Med; 1973 Oct; 289(14):744-5. PubMed ID: 4727533
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement-mediated lysis in different cationic media of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria.
    Pizzimenti MC; Vacs E; Dalmasso AP
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):215-9. PubMed ID: 4812854
    [No Abstract]   [Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria. Hemolysis initiated by the C3 activator system.
    Götze O; Müller-Eberhard HJ
    N Engl J Med; 1972 Jan; 286(4):180-4. PubMed ID: 5007123
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria. Alternate-complement-pathway-mediated lysis induced by magnesium.
    May JE; Rosse W; Frank MM
    N Engl J Med; 1973 Oct; 289(14):705-9. PubMed ID: 4727529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.